These data validate the concerns raised by the cIMPACT-NOW updates and the WHO 2021 classification regarding the heterogeneity of histologically diagnosed low-grade IDH-wt astrocytomas. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).